454 related articles for article (PubMed ID: 22289741)
1. Recent developments in targeting carbonic anhydrase IX for cancer therapeutics.
McDonald PC; Winum JY; Supuran CT; Dedhar S
Oncotarget; 2012 Jan; 3(1):84-97. PubMed ID: 22289741
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain.
Zatovicova M; Jelenska L; Hulikova A; Csaderova L; Ditte Z; Ditte P; Goliasova T; Pastorek J; Pastorekova S
Curr Pharm Des; 2010; 16(29):3255-63. PubMed ID: 20819068
[TBL] [Abstract][Full Text] [Related]
3. Targeting carbonic anhydrase IX activity and expression.
Mahon BP; Pinard MA; McKenna R
Molecules; 2015 Jan; 20(2):2323-48. PubMed ID: 25647573
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase IX (CAIX) as a mediator of hypoxia-induced stress response in cancer cells.
McDonald PC; Dedhar S
Subcell Biochem; 2014; 75():255-69. PubMed ID: 24146383
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases.
Tafreshi NK; Lloyd MC; Bui MM; Gillies RJ; Morse DL
Subcell Biochem; 2014; 75():221-54. PubMed ID: 24146382
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use.
Pastorek J; Pastorekova S
Semin Cancer Biol; 2015 Apr; 31():52-64. PubMed ID: 25117006
[TBL] [Abstract][Full Text] [Related]
7. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion.
Robertson N; Potter C; Harris AL
Cancer Res; 2004 Sep; 64(17):6160-5. PubMed ID: 15342400
[TBL] [Abstract][Full Text] [Related]
8. Targeting carbonic anhydrase IX with small organic ligands.
Wichert M; Krall N
Curr Opin Chem Biol; 2015 Jun; 26():48-54. PubMed ID: 25721398
[TBL] [Abstract][Full Text] [Related]
9. Optimization of a novel peptide ligand targeting human carbonic anhydrase IX.
Rana S; Nissen F; Marr A; Markert A; Altmann A; Mier W; Debus J; Haberkorn U; Askoxylakis V
PLoS One; 2012; 7(5):e38279. PubMed ID: 22693612
[TBL] [Abstract][Full Text] [Related]
10. Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study.
Capkova L; Koubkova L; Kodet R
Neoplasma; 2014; 61(2):161-9. PubMed ID: 24471939
[TBL] [Abstract][Full Text] [Related]
11. Binding of the phage display derived peptide CaIX-P1 on human colorectal carcinoma cells correlates with the expression of carbonic anhydrase IX.
Askoxylakis V; Ehemann V; Rana S; Krämer S; Rahbari NN; Debus J; Haberkorn U
Int J Mol Sci; 2012 Oct; 13(10):13030-48. PubMed ID: 23202936
[TBL] [Abstract][Full Text] [Related]
12. Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase.
Kaluz S; Kaluzová M; Chrastina A; Olive PL; Pastoreková S; Pastorek J; Lerman MI; Stanbridge EJ
Cancer Res; 2002 Aug; 62(15):4469-77. PubMed ID: 12154057
[TBL] [Abstract][Full Text] [Related]
13. Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs.
Thiry A; Supuran CT; Masereel B; Dogné JM
J Med Chem; 2008 Jun; 51(11):3051-6. PubMed ID: 18348513
[No Abstract] [Full Text] [Related]
14. Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs.
Dubois L; Peeters SG; van Kuijk SJ; Yaromina A; Lieuwes NG; Saraya R; Biemans R; Rami M; Parvathaneni NK; Vullo D; Vooijs M; Supuran CT; Winum JY; Lambin P
Radiother Oncol; 2013 Sep; 108(3):523-8. PubMed ID: 23849171
[TBL] [Abstract][Full Text] [Related]
15. Expression and activity of carbonic anhydrase IX is associated with metabolic dysfunction in MDA-MB-231 breast cancer cells.
Li Y; Wang H; Oosterwijk E; Tu C; Shiverick KT; Silverman DN; Frost SC
Cancer Invest; 2009 Jul; 27(6):613-23. PubMed ID: 19367501
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells.
Ivanova L; Zandberga E; Siliņa K; Kalniņa Z; Ābols A; Endzeliņš E; Vendina I; Romanchikova N; Hegmane A; Trapencieris P; Eglītis J; Linē A
Cancer Chemother Pharmacol; 2015 Feb; 75(2):235-46. PubMed ID: 25422154
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
[TBL] [Abstract][Full Text] [Related]
18. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
[TBL] [Abstract][Full Text] [Related]
19. Carbonic Anhydrase IX in Renal Cell Carcinoma, Implications for Disease Management.
Courcier J; de la Taille A; Nourieh M; Leguerney I; Lassau N; Ingels A
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998233
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9.
Petrul HM; Schatz CA; Kopitz CC; Adnane L; McCabe TJ; Trail P; Ha S; Chang YS; Voznesensky A; Ranges G; Tamburini PP
Mol Cancer Ther; 2012 Feb; 11(2):340-9. PubMed ID: 22147747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]